CD34 and neoplasm: This paper shows that monocytes with similar characteristics as CB CD34+ cell-derived monocytes, consisting of CD14++CD16+ and CD14+CD16− subsets, can be generated and exhibited APC capacity and cytotoxicity against tumour cells.